Markets:

Overview

News

Currencies

International

Treasuries

Anebulo Pharmaceuticals, Inc. - Common Stock (NQ:ANEB)

1.120 -0.080 (-6.67%)

Streaming Delayed Price Updated: 3:43 PM EST, Dec 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Anebulo Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer

December 22, 2025

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates

November 13, 2025

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates

September 29, 2025

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity

September 25, 2025

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Deal Dispatch: Need M&A Approval? FCC Chair Explains How To Get It ↗

September 19, 2025

The "Jimmy Kimmel Live" drama coincided with reports of tit-for-tat maneuvering between the FCC and corporations desperate for deal approval.

Via Benzinga

Which stocks are gapping on Friday? ↗

September 12, 2025

Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

Top movers in Friday's pre-market session ↗

September 12, 2025

The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 12, 2025

Via Benzinga

Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives

September 12, 2025

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

July 24, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

Crude Oil Falls; Thermo Fisher Scientific Earnings Top Views ↗

July 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 23, 2025

Via Benzinga

Dow Surges Over 200 Points; AT&T Posts Upbeat Earnings ↗

July 23, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 23, 2025

Via Benzinga

Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock

July 23, 2025

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates

May 13, 2025

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 13, 2025

Via Benzinga

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates

February 14, 2025

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 24, 2024

Via Benzinga

Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise

December 23, 2024

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates

November 13, 2024

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates

September 25, 2024

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects

July 22, 2024

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Lifecore Biomedical Announces Cooperation Agreement with 22NW

July 01, 2024

Provides for the Addition of 22NW Nominees Jason Aryeh and Matthew Korenberg, as Well as Humberto Antunes and Paul Johnson, to the Board

From Lifecore Biomedical, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 31, 2024

Via Benzinga

ANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024 ↗

May 15, 2024

ANEB stock results show that Anebulo Pharmaceuticals beat analyst estimates for earnings per share the third quarter of 2024.

Via InvestorPlace

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates

May 15, 2024

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.